Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, today ...

The 200-acre Lilly Medicine Foundry is expected to add 400 full-time jobs for highly skilled workers, including engineers, ...

Spain's Naturgy plans to buy back almost 2.5-billion euros ($2.6 billion) of its shares, up to 10% of its capital, then ...

Lebanon Plan Commission on Monday night unanimously approved a design plan for Eli Lilly and Co.’s $4.5 billion center for advanced manufacturing and drug development at the LEAP Research and ...

Travis Coy is using his Big Pharma bona fides to prioritize business development at the diversified and growing company.

Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...

As HR's strategic role evolves, people professionals must leverage tech alongside human skills to drive success, says BVI ...

Ventus Therapeutics, a clinical-stage biopharmaceutical company with two novel small-molecule programs entering Phase 2 development for immunology, inflammation, and neurology disorders, today ...

Perceive Pharma, a pharmaceutical company pioneering novel small molecule therapeutics in ophthalmology, today announced the closing of a $15M Series A funding round including Deerfield Management, ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

A beloved company that has been part of the fabric of the US and has served hundreds of millions of customers around the ...